Endolysins as therapeutics: bridging preclinical development and clinical manufacturing

Tim Thysens

Tim Thysens

Eurofins

Tim Thysens is active as Business Development Manager at Eurofins CDMO, where he focuses mainly on biologicals. With 4 years of experience in the CDMO landscape, Tim has played a pivotal role in implementing a cell line development platform at Eurofins CDMO and has been instrumental in projects involving process optimization, upscaling, and GMP manufacturing of biologics. He holds a PhD from KU Leuven and has contributed to multiple scientific publications. Tim will be speaking about challenges regarding the manufacturing of endolysins as therapeutics, sharing insights drawn from recent endolysin-based projects performed at Eurofins CDMO.

Authors: Thysens, T1

Affiliations: Eurofins CDMO